Trials / Conditions / Respiratory Syncytial Virus (RSV) Infection
Respiratory Syncytial Virus (RSV) Infection
5 registered clinical trials studyying Respiratory Syncytial Virus (RSV) Infection — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related NCT07164430 | Nicola Irwin | — |
| Active Not Recruiting | A Phase 2 Study to Describe the Safety and Immunogenicity of Respiratory Syncytial Virus Vaccine IN006 in Heal NCT07128121 | Shenzhen Shenxin Biotechnology Co., Ltd | Phase 2 |
| Not Yet Recruiting | Assessing the Burden of Respiratory Syncytial Virus (RSV) NCT07015255 | Abu Dhabi Health Services Company | — |
| Recruiting | In-depth Analysis of the Immune Responses in the Upper Respiratory Tract in Older Adults Infected or Colonized NCT06998251 | University Hospital, Geneva | — |
| Completed | Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study NCT02718937 | Biota Pharma Europe Limited | Phase 2 |